Patterns of Polysubstance Use Among Non-Hispanic White and American Indian/Alaska Native Adolescents: An Exploratory Analysis

Lee Kiedrowski, MS¹; Arielle Selya, PhD^2,3,4 (View author affiliations)

Suggested citation for this article: Kiedrowski L, Selya A. Patterns of Polysubstance Use Among Non-Hispanic White and American Indian/Alaska Native Adolescents: An Exploratory Analysis. Prev Chronic Dis 2019;16:180108. DOI: http://dx.doi.org/10.5888/pcd16.180108external icon.

PEER REVIEWED

Abstract

Introduction

The prevalence of polysubstance use is well described, but less is known about correlates and patterns of polysubstance use. Previous research characterized latent subgroups of substance users by the type substance used. Racial disparities in the prevalence of polysubstance use exist, particularly for American Indian/Alaska Native (AI/AN) populations. The objective of our study was to describe differences in patterns of polysubstance use between non-Hispanic white and AI/AN adolescents.

Methods

We obtained data from the 2013 Youth Risk Behavior Survey (YRBS). We analyzed substance use patterns (cigarettes, alcohol, marijuana, cocaine, inhalants, heroin, methamphetamines, ecstasy, steroids, and injected drugs) separately among 375 AI/AN and 15,633 non-Hispanic white adolescents. We calculated pairwise correlations. Exploratory factor analysis identified latent factors of polysubstance use patterns.

Results

The use of all substances by AI/AN adolescents was the same or higher than use by non-Hispanic white adolescents, particularly for cocaine, heroin, and steroids. We found strong correlations between use of heroin and injected drugs and between use of cocaine and ecstasy among both populations. We found a latent factor for cigarettes, alcohol, and marijuana and another factor for broad polysubstance use among both populations. We found a factor for steroids and injected drugs among AI/AN adolescents, a factor for cocaine and ecstasy among non-Hispanic white adolescents, and a unique factor for methamphetamines.

Conclusion

Differences in substance use patterns exist between AI/AN and non-Hispanic white adolescents, particularly for illegal drug use. If validated in future research, information on these differences could be used to inform tailored intervention programs aimed at preventing substance use.

Top

Introduction

Substance use is well understood to have negative, life-long consequences. Particularly concerning is the use of substances among adolescents, because initiation often occurs during these formative years, thus increasing the likelihood of addiction and continued use (1). In 2013, 7.8% of adolescents used tobacco, 22.7% drank alcohol, and 8.8% used illegal drugs (2,3).

Prevalence of substance use is well known for individual substances at the general population level; however, substance use differs widely across subgroups of the population. For example, with the exception of alcohol, substance use is more prevalent among American Indian/Alaska Native (AI/AN) populations than among white populations (3). In addition to racial disparities in the prevalence of substance use, racial differences in risk factors and correlates of risky behaviors exist (4–6).

Even after accounting for demographic characteristics, adolescent populations have distinct heterogeneous subgroups (ie, latent classes) that differ in their patterns of polysubstance use (7–9). Common subgroups include nonusers or infrequent users, broad polysubstance users, and users of 1 or more substances (7), such as alcohol (7,8,10) or dual use of marijuana and cigarettes (8). These subgroups differ in their environmental-level and/or individual-level risk factors for substance use (7).

Considering that racial differences exist among these social and environmental risk factors for substance use, it is plausible that common patterns of substance use could fundamentally differ by racial or ethnic group. Little is known about whether such differences in patterns of substance use exist between AI/AN and non-Hispanic white adolescents. If differences do exist, then that information could be used to identify adolescents at higher risk for polysubstance use. Effective treatment plans and education could then be designed and implemented to prevent additional substance use. Our study used data from the 2013 Youth Risk Behavior Survey (YRBS) to examine potential differences in correlations and patterns of substance use between AI/AN and non-Hispanic white adolescents.

Top

Methods

We used publicly available data from the 2013 YRBS (the most recent data available at the beginning of this research, in March 2015). The YRBS is an observational, cross-sectional survey designed in 1990 by the Centers for Disease Control and Prevention to monitor the leading risk behaviors of US adolescents and young adults that contribute to death, disability, and social problems (11).

We limited our analysis to 2 self-reported race/ethnicities: AI/AN (n = 1,096) and non-Hispanic white (n = 45,187). We found a substantial amount of missing data on substance use variables, which was handled with listwise deletion, resulting in a final sample size of 375 AI/AN adolescents and 15,633 non-Hispanic white adolescents. We used listwise deletion because research shows that it is preferable to other methods (eg, imputation) in pattern-based analyses such as ours (12).

The University of North Dakota Institutional Review Board approved this study. All analyses were conducted at the University of North Dakota, Grand Forks, North Dakota, from March 2015 through February 2018.

Measures

We analyzed survey data on the following substances: tobacco (cigarettes), alcohol, marijuana, cocaine, inhalants, heroin, methamphetamines, ecstasy, steroids, and injected drugs.

Cigarette and alcohol use were each assessed by the self-reported number of days of the past 30 days that each substance was used. Original responses were given as 0 days, 1 or 2 days, 3 to 5 days, 6 to 9 days, 10 to 19 days, 20 to 29 days, or all 30 days. We used the midpoint value of each category for the analyses of the responses.

Marijuana was assessed by the self-reported number of lifetime uses of marijuana. Original responses were given as 0 times, 1 or 2 times, 3 to 9 times, 10 to 19 times, 20 to 39 times, 40 to 99 times, or 100 or more times. We used the midpoint value of each category for the analyses of the responses, and values were top coded at 100.

Cocaine (including “powder, crack, or freebase”), inhalants (including “glue, aerosol spray cans, paints, or sprays to get high”), heroin (including “smack, junk, or China white”), methamphetamines (including “speed, crystal, crank, or ice”), ecstasy (including “MDMA”), and steroids (“steroid pills or shots without a doctor’s prescription”) were assessed by the self-reported number of days in the participant’s lifetime that each substance was used. Original responses were given as 0 times, 1 or 2 times, 3 to 9 times, 10 to 19 times, 20 to 39 times, or 40 or more times. We used the midpoint value of each category for the analyses of the responses, and values were top coded at 40.

The use of injected drugs (“used a needle to inject any illegal drug”) was assessed by the self-reported number of days in the participant’s lifetime that the substance was used. Original responses were given as 0 times, 1 time, or 2 or more times. These values were analyzed numerically and were top coded at 2.

Analysis

The YRBS has a complex, multistage sampling process, and survey weights are available to account for this sampling design in standard analyses (eg, regressions). However, we intentionally did not account for survey weights because 1) our study was exploratory and 2) standard and automatic procedures for incorporating survey weights are lacking for the type of analysis we conducted. In other words, our focus was to examine broad, qualitative differences in patterns of polysubstance use across AI/AN and non-Hispanic white samples rather than to produce population-level parameter estimates.

To quantify the pairwise association between each possible pair of substances, we calculated Spearman ρ, a nonparametric correlation statistic; we used a nonparametric test because the data were not normally distributed. We adjusted for multiple comparisons of the Spearman ρ test by using the Bonferroni correction. We then visualized all pairwise correlations simultaneously by creating a heatmap.

Next, we performed an exploratory factor analysis on each group to identify latent factors based on substance use patterns among each group. Exploratory factor analysis tests the hypothesis that each group (non-Hispanic white and AI/AN) contains subgroups with fundamentally different substance use patterns. Preliminary analyses based on scree plots (not shown) suggested that the optimal number of factors was 2 to 5 factors for the AI/AN group and 4 or 5 factors for the non-Hispanic white group. We selected the final number of factors on the basis of interpretability, model fit, and simplicity of structure (ie, single-loading of variables onto factors with a threshold of 0.3). We used oblique rotation to allow correlation between the latent factors and ordinary least squares factoring to find the minimum residual solution while accounting for nonnormality among variables. We used the Tucker-Lewis Index and the root-mean-square error of approximation to evaluate the goodness-of-fit for the exploratory factor analysis. A Tucker-Lewis Index of 0.9 or greater is considered a good fit (13) as is a root-mean-square error of approximation of 0.05 or less (14).

We conducted all analyses and plots by using R version 3.1.3 (R Foundation for Statistical Computing) run separately for AI/AN and non-Hispanic white samples.

Top

Results

AI/AN adolescents had a higher rate than non-Hispanic white adolescents of past 30-day use of tobacco and alcohol and lifetime use of marijuana, cocaine, inhalants, heroin, methamphetamines, ecstasy, steroids, and injected drugs (Table 1). Among users of each substance, the median frequency of use was the same or higher among AI/AN adolescents, with large differences found in use of cocaine (14.5 vs 6.0 lifetime uses), heroin (22.0 vs 1.5 lifetime uses), and steroids (29.5 vs 6.0 lifetime uses).

Pairwise correlations showed strong similarities across groups in which pairs of substances were correlated with each other and, in general, the correlations were slightly stronger among AI/AN adolescents than among non-Hispanic white adolescents (Figure). The top 3 pairwise correlations for AI/AN adolescents were heroin with injected drugs (ρ = 0.669, P < .001), cocaine with methamphetamines (ρ = 0.661, P < .001), and steroids with injected drugs (ρ = 0.599, P < .001). The top 3 pairwise correlations for non-Hispanic white adolescents were cocaine with methamphetamines (ρ = 0.614, P < .001), heroin with injected drugs (ρ = 0.608, P < .001), and cigarettes with marijuana (ρ = 0.585, P < .001). Cocaine with methamphetamine and heroin with injected drugs were in the top 3 most strongly correlated pairs among both AI/AN and non-Hispanic white adolescents.

Figure.
Pairwise correlations (Spearman ρ) among American Indian/Alaska Native and non-Hispanic white adolescents, Youth Risk Behavior Survey, 2013. Each pair of drugs is represented as a square. Abbreviation: Meth, methamphetamine. [A text version of this figure is also available].

In the exploratory factor analyses, a 3-factor solution was chosen for the AI/AN group, and a 4-factor solution was chosen for the non-Hispanic white group (Table 2). Both models showed good fit (Tucker-Lewis Index = 0.91, root-mean-square error of approximation = 0.008 for AI/AN adolescents; Tucker-Lewis Index = 0.99, root-mean-square error of approximation = 0.001 for non-Hispanic white adolescents). Among AI/AN adolescents, one of the latent factors was associated with use of cocaine, ecstasy, heroin, methamphetamines, and inhalants; the second latent factor was associated with use of injected drugs and steroids; and the third latent factor was associated with use of cigarettes, marijuana, and alcohol. Among non-Hispanic white adolescents, one of the latent factors was associated with use of heroin, injected drugs, steroids, and inhalants; the second latent factor was associated with use of cigarettes, marijuana, and alcohol; the third latent factor was associated with use of methamphetamines; and the fourth latent factor was associated with use of ecstasy and cocaine.

These results identified both similarities and differences among AI/AN and non-Hispanic white adolescents. Both groups had a distinct latent factor for cigarettes, alcohol, and marijuana. Other commonalities included a link between 1) heroin and inhalants, 2) steroids and injected drugs, and 3) cocaine and ecstasy. One prominent difference was that methamphetamine was its own independent variable among non-Hispanic white adolescents, but it was linked with other substances among AI/AN adolescents. Additionally, steroids and injected drugs comprised their own latent factor among AI/AN adolescents, whereas cocaine and ecstasy comprised their own latent factor among non-Hispanic white adolescents.

Top

Discussion

We conducted an exploratory analysis of differences in substance use patterns among AI/AN and non-Hispanic white adolescents in the United States. Pairwise correlations overall showed similar patterns of substance use, particularly for heroin with injected drugs and cocaine with methamphetamines, although the strength of correlations was generally higher among AI/AN adolescents. Exploratory factor analysis identified a common factor for cigarettes, alcohol, and marijuana across both groups, but distinct factors also emerged in each group. Among AI/AN adolescents, injected drugs and steroids comprised a latent factor, whereas among non-Hispanic white adolescents, cocaine and ecstasy comprised a separate latent factor, and methamphetamine alone loaded onto its own factor.

Our study parallels well-known findings about substance use disparities across racial/ethnic groups in adults (15–22). It adds to this body of knowledge by describing differences among adolescents, in particular showing a higher prevalence of substance use among AI/AN adolescents than among non-Hispanic white adolescents. The primary focus of our study, however, extends beyond the prevalence of substance use by examining differences in correlations and patterns of polysubstance use between AI/AN and non-Hispanic white adolescents, about which little is known. Our findings that AI/AN and non-Hispanic white adolescents have different patterns of substance use is consistent in a broader sense with previous findings that risk factors for risky behavior differ between these 2 populations (4–6).

One pattern of substance use common among both AI/AN and non-Hispanic white adolescents was the combination of cocaine and ecstasy; these were strongly associated according to both the correlation analysis and the exploratory factor analysis. Other remarkable correlations in both populations were cigarettes with marijuana and alcohol. Both the heatmap and the factor analysis indicated that if an adolescent used cocaine, he or she would be more likely than not to have also used ecstasy, heroin, methamphetamines, or inhalants. Likewise, if an adolescent used cigarettes, he or she would be more likely than not to have used marijuana and alcohol. Our findings are broadly consistent with previous research on latent classes of substance use (7) in that a pattern emerged for “lighter” substance use (cigarettes, alcohol, and marijuana) and other patterns emerged for “heavier” substance use (substances that are illegal at any age).

We found notable differences between AI/AN and non-Hispanic white adolescents in illegal substance use. In particular, nonmedical steroid use and injected drugs were associated with both AI/AN and non-Hispanic white adolescents, but this pairing comprised its own unique factor among AI/AN adolescents. This pairing indicates that AI/AN adolescents who illicitly use steroids and injected drugs are a distinct subpopulation of AI/AN adolescents. A link between steroid use and injected drugs was reported previously (23), but to our knowledge, this link has not been reported among AI/AN adolescents. Distinct subpopulations of non-Hispanic white adolescents were uniquely characterized by methamphetamine use, indicating that non-Hispanic white methamphetamine users are a distinct subpopulation of non-Hispanic white adolescents. We found this unique characterization despite the overall lower prevalence of methamphetamine use among non-Hispanic white adolescents than among AI/AN adolescents. Similarly, cocaine and ecstasy use characterized another subpopulation of non-Hispanic white adolescents.

Future research should focus on replicating these patterns in other independent samples, examining temporality and possible causality and further refining the exact nature (eg, which drugs are injected and what type of steroids are being used) and timing (eg, whether cocaine and ecstasy are being taken together in a single episode) of these patterns. Validation of racial/ethnic differences in polysubstance use patterns would motivate the development of tailored interventions for subgroups to prevent or reduce the prevalence of polysubstance use.

Strengths of our study include the novel use of exploratory methods to assess polysubstance abuse among AI/AN and non-Hispanic white adolescents. Additionally, our study extends previous research on racial/ethnic disparities in the prevalence of use to examine patterns of polysubstance use. Finally, our study used a large, national data set, which increases the generalizability of the findings to the larger population of high school–aged students in the United States.

Our study had several limitations. First, it used cross-sectional data, which cannot be used to assess causality or rule out residual confounding. Second, because YRBS data are self-reported, they are subject to social desirability and recall biases. Third, the use of cigarettes and alcohol were measured in “use within the past 30 days,” while all other substances were measured in “lifetime use.” This difference results in imperfect direct comparisons between substances. Fourth, the YRBSS has a large degree of missing data on substance use, and these data may not be missing at random. For example, because the sample is limited to students who were at school on the day of the survey, truancy could have affected the findings, especially since truancy is known to be associated with substance use. The patterns of missing data may have affected our findings in unknown ways, and thus the findings should be considered exploratory only. Fifth, it was not possible to examine national YRBS public use data by state or region, and because AI/AN subpopulations can differ by state or region in important ways, further research is needed to explore these differences. Sixth, factor analysis should be considered an exploratory method, and the results may be sensitive to the particular sample or to the specific method of measuring the latent factors (eg, the wording of the questions). Additionally, factor analysis is somewhat subjective, particularly in the way factors are interpreted and the role of interpretability in selecting the number of factors. Finally, several of the substance use items, such as steroids, inhalants, and injected drugs, were broadly defined, and detailed information on the exact substance was not available.

The practicality of our study is noteworthy. The data show strong pairwise correlations between common substances of abuse and classify AI/AN and non-Hispanic white adolescents into well-structured latent factors, indicating that distinct patterns of polysubstance use exist in each subpopulation. A health care professional could use this information to inquire about substance use if a substance is known to be used and subsequently educate susceptible adolescents about substance use habits with the goal of preventing polysubstance abuse. Public health interventions and policy makers can also use these data to formulate strategies for reaching certain racial/ethnic groups to decrease the prevalence of substance abuse with more efficiency and effectiveness.

Top

Acknowledgments

This research was supported in part by the National Institutes of General Medical Sciences of the National Institutes of Health under award no. 1P20GM121341, and the Research Experience for Medical Students Program at the University of North Dakota School of Medicine and Health Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We acknowledge Dr Cristina Oancea, PhD, and Dawn Hackman for their expertise and guidance with this study. No copyrighted material or copyrighted surveys, instruments, or tools were used.

Top

Author Information

Corresponding Author: Lee Kiedrowski, MS, 1301 N Columbia Rd, Grand Forks, ND 58203-2898. Telephone: 701-777-2514. Email: lee.kiedrowski@und.edu.

Author Affiliations: ¹University of North Dakota School of Medicine & Health Sciences, Grand Forks, North Dakota. ²Department of Population Health, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota. ³Behavioral Sciences Group, Sanford Research, Sioux Falls, South Dakota. ⁴Department of Pediatrics, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.

Top

References

1. US Department of Health and Human Services, National Institute of Health, National Institute on Drug Abuse. Preventing drug abuse among children and adolescents: a research-based guide. Vol 04-4212(A); 2003. https://www.drugabuse.gov/sites/default/files/preventingdruguse_2.pdf. Accessed February 1, 2018.
2. Kasza KA, Ambrose BK, Conway KP, Borek N, Taylor K, Goniewicz ML, et al. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med 2017;376(4):342–53. CrossRefexternal icon PubMedexternal icon
3. Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. 2014. http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.pdf. Accessed February 1, 2018.
4. Whitesell NR, Beals J, Crow CB, Mitchell CM, Novins DK. Epidemiology and etiology of substance use among American Indians and Alaska Natives: risk, protection, and implications for prevention. Am J Drug Alcohol Abuse 2012;38(5):376–82. CrossRefexternal icon PubMedexternal icon
5. Stanley LR, Swaim RC. Initiation of alcohol, marijuana, and inhalant use by American-Indian and white youth living on or near reservations. Drug Alcohol Depend 2015;155:90–6. CrossRefexternal icon PubMedexternal icon
6. Manzo K, Tiesman H, Stewart J, Hobbs GR, Knox SS. A comparison of risk factors associated with suicide ideation/attempts in American Indian and white youth in Montana. Arch Suicide Res 2015;19(1):89–102. CrossRefexternal icon PubMedexternal icon
7. Tomczyk S, Isensee B, Hanewinkel R. Latent classes of polysubstance use among adolescents — a systematic review. Drug Alcohol Depend 2016;160:12–29. CrossRefexternal icon PubMedexternal icon
8. Trenz RC, Scherer M, Duncan A, Harrell PT, Moleko AG, Latimer WW. Latent class analysis of polysubstance use, sexual risk behaviors, and infectious disease among South African drug users. Drug Alcohol Depend 2013;132(3):441–8. CrossRefexternal icon PubMedexternal icon
9. Chan GCK, Kelly AB, Carroll A, Williams JW. Peer drug use and adolescent polysubstance use: do parenting and school factors moderate this association? Addict Behav 2017;64:78–81. CrossRefexternal icon PubMedexternal icon
10. Tomczyk S, Pedersen A, Hanewinkel R, Isensee B, Morgenstern M. Polysubstance use patterns and trajectories in vocational students — a latent transition analysis. Addict Behav 2016;58:136–41. CrossRefexternal icon PubMedexternal icon
11. Centers for Disease Control and Prevention. YRBSS data and documentation. 2013. https://www.cdc.gov/healthyyouth/data/yrbs/data.htm. Accessed December 29, 2015.
12. Selya A, Anshutz D. Machine learning for predicting health outcomes: an example of predicting obesity from dietary and physical activity patterns. In: Mago VK, Giabbanelli PJ, Papageorgiou EI, editors. Cham (CH): Advanced Data Analytics in Healthcare; 2018.
13. Bentler PM, Bonett DG. Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull 1980;88(3):588–606. CrossRefexternal icon
14. Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen KA, Long JS, editors. Testing structural equation models. Newbury Park (CA): Sage; 1993. p. 136–62.
15. Davis MM, Spurlock M, Dulacki K, Meath T, Li HF, McCarty D, et al. Disparities in alcohol, drug use, and mental health condition prevalence and access to care in rural, isolated, and reservation areas: findings from the South Dakota health survey. J Rural Health 2016;32(3):287–302. CrossRefexternal icon PubMedexternal icon
16. Beauvais F, Jumper-Thurman P, Burnside M. The changing patterns of drug use among American Indian students over the past 30 years. Am Indian Alsk Native Ment Health Res 2008;15(2):15–24. CrossRefexternal icon PubMedexternal icon
17. Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 1992;112(1):64–105. CrossRefexternal icon PubMedexternal icon
18. Kunitz SJ. Risk factors for polydrug use in a Native American population. Subst Use Misuse 2008;43(3-4):331–9. CrossRefexternal icon PubMedexternal icon
19. Mitchell CM, Novins DK, Holmes T. Marijuana use among American Indian adolescents: a growth curve analysis from ages 14 through 20 years. J Am Acad Child Adolesc Psychiatry 1999;38(1):72–8. CrossRefexternal icon PubMedexternal icon
20. Whitbeck LB, Yu M, Johnson KD, Hoyt DR, Walls ML. Diagnostic prevalence rates from early to mid-adolescence among indigenous adolescents: first results from a longitudinal study. J Am Acad Child Adolesc Psychiatry 2008;47(8):890–900. CrossRefexternal icon PubMedexternal icon
21. Whitesell NR, Beals J, Mitchell CM, Keane EM, Spicer P, Turner RJ. The relationship of cumulative and proximal adversity to onset of substance dependence symptoms in two American Indian communities. Drug Alcohol Depend 2007;91(2-3):279–88. CrossRefexternal icon PubMedexternal icon
22. Anthony JC, Petronis KR. Early-onset drug use and risk of later drug problems. Drug Alcohol Depend 1995;40(1):9–15. CrossRefexternal icon PubMedexternal icon
23. Dodge T, Hoagland MF. The use of anabolic androgenic steroids and polypharmacy: a review of the literature. Drug Alcohol Depend 2011;114(2-3):100–9. CrossRefexternal icon PubMedexternal icon

Top

Tables

^a Data source: Centers for Disease Control and Prevention (11). Frequency for cigarette and alcohol use was defined as the number of days used in the past 30 days. For all other substances, frequency refers to the number of days used in lifetime. Continuous variables are summarized as median (interquartile range). Categorical variables are summarized as number (percentage).

^a Data source: Centers for Disease Control and Prevention (11). The loading of each variable of substance use onto each factor is shown; blank cells indicate that the loading was below the threshold of 0.3.

Top